Mixed Culture Patents (Class 435/252.4)
  • Patent number: 7429477
    Abstract: Fungal/bacterial antagonist combinations, a seed coated with one of the combinations and a plant protected from plant pathogens by one of the combinations. The invention is also a fungal/bacterial antagonist combination comprising a Trichoderma virens fungal antagonist and a Bacillus subtilis var. amyloliquefaciens (Bacillus amyloliquefaciens) bacterial antagonist and its use for controlling plant pathogens as a biocontrol agent, bio-pesticide or bio-fungicide. The invention also finds utility as a fungal/bacterial antagonist combination applied to the seed, stalk or leaf that results in an increase in plant yield. Control of early and late season stalk and root rot caused by fungi such as Fusarium, Phythium, Phytophthora and Penicillium in tomatoes, peppers, turf grass, soybeans, sunflower, wheat and corn is achieved.
    Type: Grant
    Filed: September 13, 2004
    Date of Patent: September 30, 2008
    Inventor: Thomas D. Johnson
  • Patent number: 7425440
    Abstract: A culture flask 10 comprises two or more internal chambers 18-21 defining a plurality of parallel surfaces of different sizes and means for fluid communication 24 between the chambers 18-20.
    Type: Grant
    Filed: June 9, 2004
    Date of Patent: September 16, 2008
    Assignee: The Automation Partnership (Cambridge) Limited
    Inventors: David S Malinge, Richard Wales, Peter Esser, Stephen Guy
  • Publication number: 20080213865
    Abstract: A compound microbial preparation includes multiple single microbial series, hormones produced from each of those multiple single microbial series separately cultivated, and hormones produced from cross cultivation among those multiple single microbial series to be applied in modifying soil quality, activating soil, effectively degrading soil pollution, and helping growth of crops.
    Type: Application
    Filed: March 1, 2007
    Publication date: September 4, 2008
    Inventor: Wen-Hsiung Lai
  • Patent number: 7416879
    Abstract: An isolated microbial consortium is described that includes a first microbial consortium having Thermacetogenium phaeum to metabolize a complex hydrocarbon substrate into metabolic products comprising an acetate compound. The consortium also includes a second microbial consortium having a methanogen to convert the acetate compound into a final product that includes methane. Also, a method of increasing production of materials with enhanced hydrogen content. The method includes isolating Thermacetogenium phaeum from geologic formation water, culturing the isolated Thermacetogenium phaeum to increase the Thermacetogenium phaeum population, and introducing a consortium of the cultured Thermacetogenium phaeum, which may include spores of Thermacetogenium phaeum, into a hydrocarbon formation containing a complex hydrocarbon substrate.
    Type: Grant
    Filed: January 11, 2006
    Date of Patent: August 26, 2008
    Assignee: LUCA Technologies, Inc.
    Inventors: Robert S. Pfeiffer, Glenn A. Ulrich, Gary Vanzin
  • Patent number: 7410791
    Abstract: The invention provides a device for adhering cells in a specific and predetermined position, and associated methods. The device includes a plate defining a surface and a plurality of cytophilic islands that adhere cells, isolated by cytophobic regions to which cells do not adhere, contiguous with the cytophilic islands. The islands or the regions or both may be formed of a self-assembled monolayer (SAM).
    Type: Grant
    Filed: January 13, 2006
    Date of Patent: August 12, 2008
    Assignees: President and Fellows of Harvard College, Children's Medical Center Corporation, Massachusetts Institute of Technology
    Inventors: Rahul Singhvi, Amit Kumar, George M. Whitesides, Donald E. Ingber, Gabriel P. Lopez, Daniel I. C. Wang, Gregory Stephanopoulos
  • Patent number: 7407794
    Abstract: The present invention relates to the use of Ulocladium oudemansii as a biological control agent. Processes and compositions for the biological control of Botrytis species using Ulocladium oudemansii are also provided.
    Type: Grant
    Filed: June 15, 2001
    Date of Patent: August 5, 2008
    Assignee: The Horticulture and Food Research Institute of New Zealand Limited
    Inventors: Philip George Elmer, Tony Reglinski, Robert Anthony Hill
  • Patent number: 7407793
    Abstract: The present invention relates to a consortium of Nitrosomonas eutropha and Nitrobacter winogradskyi, which is more effective at removing ammonia and nitrite than the commonly used consortium of Nitrosomonas europea and Nitrobacter winogradskyi, particularly in aquaculture such as shrimp ponds. Supplementation of the consortium in aquaculture such as shrimp ponds may lead to an increase in total yield, an increase in size, a decrease in Food Conversion Ratio (less food required per kg of shrimp obtained), and an increase in total per pond sales.
    Type: Grant
    Filed: October 11, 2005
    Date of Patent: August 5, 2008
    Assignee: Novozymes Biologicals, Inc.
    Inventor: David J. Drahos
  • Publication number: 20080160596
    Abstract: The present invention relates to an artificial biomembrane and a method for manufacturing such an artificial biomembrane. The beneficial microbial strains, authorized for use in the nation, are concentrated after fermentation. Film-forming raw materials in the water, such as polyvinyl alcohol, sodium alginate and sodium carboxymethyl cellulose, are dissolved into glue liquid, into which the mixture of coal-based activated carbon powder, diatomaceous earth powder sodium acetate and single strain or multiple strains of microbial cells are added. The glue liquid are set into the spray device that is pressed to spray, such that fogdrops are landed on powder beds or fluidized beds for immobilization to form artificial biomembranes. The artificial biomembranes can be manufactured by mechanization and large-scale production, with simple process of immobilization, high efficiency and low cost.
    Type: Application
    Filed: March 18, 2008
    Publication date: July 3, 2008
    Inventors: Qinsheng Li, Yeqin Wang, Ruoxue Wang, Jing Wang
  • Patent number: 7390891
    Abstract: Disclosed are nucleic acid molecules encoding polypeptides of the telomerase complex. Also disclosed are methods of preparing the nucleic acid molecules and polypeptides, and methods of using these molecules.
    Type: Grant
    Filed: October 16, 1997
    Date of Patent: June 24, 2008
    Assignee: Amgen Inc.
    Inventors: Lea Anne Harrington, Murray O. Robinson
  • Publication number: 20080124774
    Abstract: Lactobacillus bacteria having enhanced tolerance to butanols have been isolated. The bacteria are useful for the fermentive production of butanol. New methods for the isolation of butanol tolerant Lactobacillus are also provided.
    Type: Application
    Filed: June 12, 2007
    Publication date: May 29, 2008
    Inventors: MICHAEL G. BRAMUCCI, Vasantha Nagarajan, Natalia Sedkova, Manjari Singh
  • Publication number: 20080102511
    Abstract: The invention publishes a process for the joint culture of an association of microorganisms using pyrite (FeS2) as an energy source. This invention particularly publishes the use of a pyrite ore as an energy source in the joint culture of an association of Acidithiobacillus ferrooxidans and Acidithiobacillus thiooxidans type isolated microorganisms known as Wenelen DSM 16786 and Licanantay DSM 17318 respectively.
    Type: Application
    Filed: September 26, 2007
    Publication date: May 1, 2008
    Applicant: BIOSIGMA S.A.
    Inventors: Pedro Antonio Morales Cerda, Leandro Mauricio Padilla Iglesias, Ricardo Badilla Ohlbaum
  • Patent number: 7361497
    Abstract: Strains of probiotic bacteria, their isolation, characteristics and methods of use to prevent or treat carriage by a food production animal of Salmonella that causes human salmonellosis are provided. Methods for isolating and characterizing the probiotic bacteria are also provided. The present invention further provides methods for using the probiotic bacteria to prevent or treat Salmonella strains that cause human salmonellosis found in food production animals.
    Type: Grant
    Filed: October 16, 2003
    Date of Patent: April 22, 2008
    Assignee: University of Georgia Research Foundation, Inc.
    Inventors: Michael P. Doyle, Michelle D. Danyluk
  • Patent number: 7341862
    Abstract: The present invention involves the discovery of a novel endophytic fungus, Muscodor albus, which produces volatile antibiotics that are effective in the treatment of human and animal waste products. Through experimentation, this invention confirms that Muscodor albus can be used in disposable bags in connection with portable toilets to solve the problem of degradation of waste products in situations where humans are removed from sanitary facilities. This invention includes the discovery of non-volatile inhibitors that are also produced by Muscador albus and that are similarly effective in treating human and animal wastes. This invention covers a unique and novel method for preparing Muscador albus for commercial use in the treatment of human and animal wastes. This method entails infesting a seed grain with Muscador albus and then storing it under conditions that will allow the fungus to remain viable.
    Type: Grant
    Filed: March 17, 2004
    Date of Patent: March 11, 2008
    Assignee: Montana State University
    Inventors: Gary Allan Strobel, David Ezra
  • Publication number: 20070221571
    Abstract: Entrapping immobilization pellets in which microorganisms are entrapped and immobilized, the entrapping immobilization pellets comprising entrapped and immobilized purified water sludge containing nitrifying bacteria.
    Type: Application
    Filed: March 20, 2007
    Publication date: September 27, 2007
    Applicant: HITACHI PLANT TECHNOLOGIES, LTD.
    Inventors: Naoki Abe, Koutarou Aoyama, Tatsuo Sumino
  • Patent number: 7270993
    Abstract: Caulobacter optimized for use in expression of heterologous peptides as part of a hybrid Caulobacter S-layer protein are provided as well as methods for producing such Caulobacter. Caulobacter of this invention are deficient in a native Caulobacter protease that cleaves hybrid S-layer proteins. Also provided are Caulobacter libraries and methods for sorting such libraries using cell sorting technology such as FACS.
    Type: Grant
    Filed: May 22, 2002
    Date of Patent: September 18, 2007
    Assignee: The University of Bristish Columbia
    Inventors: John Smit, John F. Nomellini, Wade H. Bingle
  • Patent number: 7267816
    Abstract: Described herein are novel ammonia-oxidizing bacteria as well as isolated nucleotide sequences representative of 16S rDNA of these ammonia-oxidizing bacteria. Particular bacteria of the present invention are tolerant of freshwater environments, saltwater environments or both. Furthermore, in various embodiments, various bacteria of the present invention are capable of surviving a freeze-drying process, and may remain viable thereafter. Compositions including various combinations of the bacteria are further described, as are polymerase chain reaction (PCR) primers and oligonucleotide probes that may be used to detect these bacteria based on their 16S rDNA.
    Type: Grant
    Filed: September 10, 2003
    Date of Patent: September 11, 2007
    Assignee: Aquaria, Inc.
    Inventor: Timothy A. Hovanec
  • Patent number: 7267772
    Abstract: The invention provides a biological process for reduction of chemical and biological oxygen demand of pulp and paper industrial effluent using a mixed bacterial consortium comprising of bacterial strains isolated from natural sources which is capable of reducing chemical and biological oxygen demand of pulp and paper industrial effluent to standard discharge limits.
    Type: Grant
    Filed: December 28, 2004
    Date of Patent: September 11, 2007
    Assignee: Council of Scientific and Industrial Research
    Inventors: Rita Kumar, Deepa K. Tiku, Poonam Sharma, Anil Kumar, Rekha Chaturvedi
  • Patent number: 7235246
    Abstract: The present invention relates to the preparation of universal inactivated vaccines and their use in preparing compositions for the prophylaxis and therapy of dermatomycosis. Vaccines according to the present invention have the advantage of conferring immunity against all important causes of dermatomycosis in animals and are characterized by stable immunogenic properties, easy preparation, high content of microconidia and lack of side reactions in animals.
    Type: Grant
    Filed: April 21, 2004
    Date of Patent: June 26, 2007
    Assignee: Boehringer Ingelheim Vetmedica, GmbH
    Inventors: Igor Polyakov, Ludmilla Ivanova
  • Patent number: 7195906
    Abstract: A strain of Bifidobacterium isolated from resected and washed human gastrointestinal tract is significantly immunomodulatory following oral consumption in humans. The strain is useful in the prophylaxis and/or treatment of undesirable inflammatroy activity, especially gastrointestinal inflammatory activity such as inflammatory bowel disease or irritable bowel syndrome. The inflammatory activity may also be due to cancer.
    Type: Grant
    Filed: February 23, 2004
    Date of Patent: March 27, 2007
    Assignees: Enterprise Ireland (Trading as BioResearch Ireland), University College Cork--National University of Ireland
    Inventors: John Kevin Collins, Gerald Christopher O'Sullivan, Liam O'Mahony, Fergus Shanahan
  • Patent number: 7186544
    Abstract: Agents for promoting fattening of animals which contain as the active ingredient(s) at least one member selected from among acids originating in hexoses, non-toxic salts thereof and intramolecular esterification products thereof; and a method of promoting fattening by using these agents.
    Type: Grant
    Filed: February 3, 2004
    Date of Patent: March 6, 2007
    Assignee: Fuso Chemical Co., Ltd.
    Inventors: Hironari Koyama, Masaaki Okada
  • Patent number: 7160715
    Abstract: An isolated and purified bacterium is provided which was isolated from a high-level radioactive waste site of mixed waste. The isolate has the ability to degrade a wide variety of organic contaminants while demonstrating high tolerance to ionizing radiation. The organism is uniquely suited to bioremediation of a variety or organic contaminants while in the presence of ionizing radiation.
    Type: Grant
    Filed: April 30, 2003
    Date of Patent: January 9, 2007
    Assignee: Westinghouse Savannah River Company LLC
    Inventor: Carl B. Fliermans
  • Patent number: 7148033
    Abstract: An improved method for detection of total coliforms and E. coli comprising a broth containing an ingredient that will suppress growth of non-coliform gram negative bacteria, and at least one chromogen or fluorogen has been used effectively and is cost effective. Preferred methods include use of filter and/or plates containing the growth-promoting ingredients and the indicators.
    Type: Grant
    Filed: November 17, 2003
    Date of Patent: December 12, 2006
    Assignee: The United States of America as represented by the Administrator of the U. S. Environmental Protection Agency
    Inventors: Kristen P. Brenner, Clifford C. Rankin, Yvette R. Roybal-McKenna, Alfred P. Dufour
  • Patent number: 7078205
    Abstract: The invention provides isolated nucleic acids molecules that encode novel polypeptides. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing the nucleic acid molecules of the invention, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a sequence of the invention has been introduced or disrupted. The invention still further provides isolated proteins, fusion proteins, antigenic peptides and antibodies. Diagnostic methods utilizing compositions of the invention are also provided.
    Type: Grant
    Filed: June 7, 2002
    Date of Patent: July 18, 2006
    Assignee: Millennium Pharmaceuticals, Inc.
    Inventors: Rajasekhar Bandaru, Maria Alexandra Glucksmann, Rachel E. Meyers, Laura A. Rudolph-Owen
  • Patent number: 7070985
    Abstract: This invention relates to the discovery of a novel endophytic fungus, Muscodor albus, which produces volatile antibiotics that have been shown to be effective in the treatment of human and animal waste products. Through experimentation, this invention confirms that Muscodor albus can be used in disposable bags in connection with portable toilets to solve the problem of degradation of waste products in situations where humans are removed from sanitary facilities. This invention includes the discovery of non-volatile inhibitors that are also produced by Muscodor albus and that are similarly effective in treating human and animal wastes. This invention covers a unique and novel method for preparing Muscodor albus for commercial use in the treatment of human and animal wastes, which involves infesting barley seeds with Muscodor albus and then storing them under conditions that will allow the fungus to remain viable for up to nine months.
    Type: Grant
    Filed: April 4, 2003
    Date of Patent: July 4, 2006
    Assignee: Montana State University
    Inventors: Gary Allan Strobel, David Ezra
  • Patent number: 7067306
    Abstract: The invention provides a device for adhering cells in a specific and predetermined position, and associated methods. The device includes a plate defining a surface and a plurality of cytophilic islands that adhere cells, isolated by cytophobic regions to which cells do not adhere, contiguous with the cytophilic islands. The islands or the regions or both may be formed of a self-assembled monolayer (SAM).
    Type: Grant
    Filed: December 21, 2001
    Date of Patent: June 27, 2006
    Assignee: President & Fellows of Harvard College
    Inventors: Rahul Singhvi, Amit Kumar, George M. Whitesides, Donald E. Ingber, Gabriel P. Lopez, Daniel I. C. Wang, Gregory N. Stephanopoulos
  • Patent number: 7063836
    Abstract: The invention includes methods and compositions for treating an animal to inhibit the incidence and growth of E. coli O157:H7 and other pathogenic bacteria. The treatment method comprises administering a therapeutically effective amount of Lactobacillus acidophilus or one or a combination of a number of other probiotic bacteria to an animal. An alternative treatment method comprises administering a therapeutically effective amount of a lactic acid producing bacterium such as Lactobacillus acidophilus in combination with a lactate utilizing bacterium such as Propionibacterium freudenreichii.
    Type: Grant
    Filed: November 6, 2002
    Date of Patent: June 20, 2006
    Inventors: Bryan E. Garner, Douglas R. Ware
  • Patent number: 7052688
    Abstract: The disclosure is of a combination of lactic acid bacteria comprising: (a) a first component consisting of at least one strain of H2O2-producing lactic acid bacteria; and (b) a second component consisting of at least one strain of arginine-utilizing lactic acid bacteria. The disclosure is also of the use of this combination for making a food supplement, a hygiene product or a pharmaceutical preparation for the prevention and/or treatment of infections and inflammatory conditions caused by bacteria, viruses or fungi, especially in the mouth, vagina, urethra, nose, eyes and ears.
    Type: Grant
    Filed: December 21, 2001
    Date of Patent: May 30, 2006
    Assignee: VSL Pharmaceuticals, Inc.
    Inventor: Claudio De Simone
  • Patent number: 7022511
    Abstract: The invention provides a novel process of lignin degradation using a consortium of bacteria. To date, biodegradation of lignin has been centered to fungi only. Degradation of lignin by bacteria confer a new understanding that may be of tremendous industrial significance. This invention also discloses the isolation and acclimatization of ligninolytic bacteria from a specific site.
    Type: Grant
    Filed: March 21, 2003
    Date of Patent: April 4, 2006
    Assignee: Council of Scientific & Industrial Research
    Inventors: Rita Kumar, Anil Kumar
  • Patent number: 7001758
    Abstract: A biodegradation process for the organophosphonate product of Sarin (O-isopropyl methylphosphonofluoridate) hydrolysis, i.e., isopropylmethylphosphonate (IMPA). This process provides a feasible biodegradation demilitarization alternative to Sarin incineration. Public opposition of nerve agent incineration is widespread, and alternative methods are sought to help the U.S. Army meet the 2007 demilitarization deadline imposed by the Chemical Weapons Convention. This process uses a two-step approach to IMPA biodegradation. In the first step, a concentrated IMPA solution is used as the sole nutritional carbon and phosphorus source for microbial cultures. The second step involves diluting the culture and adding an inexpensive carbon source to encourage bacterial phosphate assimilation. The biodegradation typically involves a consortium of microorganisms comprising Methylobacterium radiotolerans GB21, Agrobacterium tumefaciens GB2GA, Klebsiella oxytoca GB2CS, GB272, Aureobacterium sp.
    Type: Grant
    Filed: May 12, 2003
    Date of Patent: February 21, 2006
    Assignee: The United States of America as represented by the Secretary of the Army
    Inventors: Ilona J. Fry, Joseph J. DeFrank, James P. Earley
  • Patent number: 6989266
    Abstract: A cement paste containing microbial cells which has a sustained effect and an excellent function of purifying water. This cement paste contains a mixture of Bacillus subtilis, Bacillus thuringiensis and Bacillus sphaericus cells at a mixing ratio by mass of 0.1 to 50:0.1 to 50:0.1 to 50.
    Type: Grant
    Filed: December 10, 2001
    Date of Patent: January 24, 2006
    Assignee: Koyoh Corporation, Ltd.
    Inventors: Masayuki Koga, Yoko Koga
  • Patent number: 6967087
    Abstract: The present invention relates to a novel obligately symbiotic thermophile Symbiobacterium toebii SC-1(Accession NO: KCTC 0685BP), and a thermostable L-tyrosine phenol-lyase and L-tryptophan indole-lyase produced by Symbiobacterium toebii SC-1. The present invention also relates to a pure culture method of Symbiobacterium toebii SC-1, a method of growth measurement for Symbiobacterium toebu SC-1 and its relative symbiotic bacteria showing low-growth yield using nitrate respiration, and a screening method of relative symbiotic strains of Symbiobacterium toebii SC-1 from the environment using a specific antibody to it. Therefore, the thermostable L-tyrosine phenol-lyase and L-tryptophan indole-lyase produced by Symbiobacterium toebii SC-1 in this invention can provide more stable catalysts in enzymatic biotransformation processes which enzymatically produce valuable medico-amino acids 3,4-dehydroxy-L-phenylalanine (L-DOPA) and L-tryptophan.
    Type: Grant
    Filed: July 14, 2000
    Date of Patent: November 22, 2005
    Assignee: Korea Research Institute of Bioscience and Biotechnology
    Inventors: Moon-Hee Sung, Seung-Goo Lee, Sung-Keun Rhee, Seung-Pyo Hong, Dae-Joong Kang, Su-Mi Kim, Chul-Joong Kim, Jin-Woo Bae, Che Ok Jeon, Joong-Jae Kim, Kwang Kim, Jae Jun Song
  • Patent number: 6953574
    Abstract: A method of producing a hydrolyzed fermented medium containing microorganisms includes providing at least one solid plant product reduced to small pieces and mixed with sugar and biocompatible liquid such as milk for fermentation at a temperature of between 35 and 58 degrees C. until the acidity of the medium reaches the range of 300 to 900 in Terner degrees. Alternatively, the medium is prepared by mixing in predetermined amounts of sprouted grains, biocompatible liquid inoculated with at least one of a variety of non-pathogenic microorganisms, vegetables, fruits, berries, high protein products, herbs, sugar, and a chemical element such as potassium. The mixture is then fermented at a selected temperature for a specified length of time to reach high acidity and high concentration of products of bacterial metabolism. A liquid phase is separated from a solid sediment phase and can be used to treat a wide variety of diseases.
    Type: Grant
    Filed: June 21, 2002
    Date of Patent: October 11, 2005
    Assignee: Technology Commercialization, Inc.
    Inventors: Constantin Vladimirovich Sobol, Yuzefa Tsezarevna Sobol
  • Patent number: 6905864
    Abstract: Polyaromatic hydrocarbons are found in contaminated soils and groundwater and are a large class of compounds for which treatment by bioremediation is sought. Accordingly, indigenous organisms that can degrade polyaromatic hydrocarbon are needed. Presented are strains of the Paenibacillus genus that degrade low molecule weight polyaromatic, and, in the presence of phenanthrene, high molecular weight polyaromatic hydrocarbons. These bacteria strains are unique among PAH-degrading bacterial strains because they form endospores and therefore can survive adverse environmental conditions. Among the strains presented are several from “P. naphthalenovorans”, a newly described species. Also presented are compositions for bioremediation comprising the bacterial strains of the invention, and a method for isolating the strains and a method for using the strains for bioremediation.
    Type: Grant
    Filed: May 24, 2002
    Date of Patent: June 14, 2005
    Assignee: Rutgers, the State University
    Inventors: Max M. Haggblom, Lori Daane
  • Patent number: 6884351
    Abstract: The present invention is directed to methods of remediating sewage matter, reducing the amount of sludge in sewage and reducing odor-causing matter in sludge. The invention is further directed to compositions having specific genetic characteristics useful in bioremediation of sewage matter and methods of producing same.
    Type: Grant
    Filed: May 7, 2003
    Date of Patent: April 26, 2005
    Inventor: Mary L. Lytal
  • Patent number: 6872399
    Abstract: The present invention relates to the preparation of universal inactivated vaccines and their use in preparing compositions for the prophylaxis and therapy of dermatomycosis. Vaccines according to the present invention have the advantage of conferring immunity against all important causes of dermatomycosis in animals and are characterized by stable immunogenic properties, easy preparation, high content of microconidia and lack of side reactions in animals.
    Type: Grant
    Filed: February 28, 2002
    Date of Patent: March 29, 2005
    Assignee: Boehringer Ingelheim Vetmedica GmbH
    Inventors: Igor Dimitriesich Polyakov, Ludmilla Ivanova
  • Patent number: 6855472
    Abstract: The invention is to provide polyhydroxyalkanoate of a novel structure enabling application to wider fields, and a producing method therefor. The invention also provides a biodegradable charge control agent having excellent charging characteristics, excellent dispersibility in the toner resin and improved spent property. The polyhydroxyalkanoate of the present invention is featured by including, in the polymer molecule, a units represented by the general formulas (1) and (2) and at least one of the units represented by the general formulas (3) to (6).
    Type: Grant
    Filed: April 29, 2002
    Date of Patent: February 15, 2005
    Assignee: Canon Kabushiki Kaisha
    Inventors: Takeshi Imamura, Etsuko Sugawa, Tetsuya Yano, Takashi Kenmoku
  • Patent number: 6841149
    Abstract: A mixture of probiotics effective to reduce the contamination of enteric bacteria in humans and other monogastric animals. The mixture of probiotics includes one or more acid-producing bacteria strains and one or more yeast strains, and may advantageously be supplemented with a source of nutrients, such as prebiotics including fructo-oligosaccharides. In a preferred embodiment, said one or more bacteria strains contain Enterococcus faecium strain NCIMB #10415, and said one or more yeast strains contain NCYC #47 and CNCM I-1079.
    Type: Grant
    Filed: July 24, 2002
    Date of Patent: January 11, 2005
    Assignees: Agri-King, Inc., Mayo Foundation for Medical Education and Research
    Inventors: David A. Spangler, Patrick K. Brown, Thomas E. Witzig
  • Publication number: 20040248278
    Abstract: Describes a new strain of Streptococcus thermophilus ssp. Salivarius (deposited on 4 Dec. 2001 at the DSMZ—Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH, Braunschweig, Germany, with accession No. DSM 14667) and edible compositions, drugs and veterinary products containing it. The use of the said strain is particularly effective in the prevention/treatment of hepatic steatosis (fatty liver) and in nonalcoholic hepatic steatosis.
    Type: Application
    Filed: April 7, 2004
    Publication date: December 9, 2004
    Inventor: Claudio De Simone
  • Patent number: 6827953
    Abstract: The present invention provides a composition comprising an untreated or treated culture of a mixed microorganism and a functional food comprising said composition. A composition comprising an untreated or treated culture of a mixed microorganism comprising at least three lactic acid bacteria selected from the group consisting of Lactobacillus delbrueckii, Lactobacillus acidophilus, Lactobacillus plantarum, Lactobacillus fermentum, Lactobacillus casei, Lactobacillus rhamnosus, Lactococcus lactis and Streptococcus thermophilus, mixed with Saccharomyces cerevisiae, and a functional food comprising said composition.
    Type: Grant
    Filed: October 4, 1999
    Date of Patent: December 7, 2004
    Assignees: Riken, A.L.A. Corporation
    Inventors: Takeo Mizutani, Ryouichi Shin, Momoyo Suzuki, Kazushi Miura
  • Patent number: 6818211
    Abstract: The invention discloses a Gram-positive microorganism, Bacillus megaterium that effectively and efficiently degrades fats, oils and grease. A composition comprising said microorganism and a method for degrading fatty acids and grease are also disclosed. Availability of glycerol to the biodegrading microorganism was discovered to enhance biodegradation.
    Type: Grant
    Filed: April 23, 2002
    Date of Patent: November 16, 2004
    Assignee: Novozymes Biologicals, Inc.
    Inventors: Jessi Lind Tisinger, Domenic A. Paone, Jonathan Leder, David J. Drahos
  • Patent number: 6812021
    Abstract: According to the present invention, a series of genes are identified in Group B Streptococcus, the products of which may be associated with the outer surface of the organism. The genes, or functional fragments thereof, may be useful in the preparation of therapeutics, e.g. vacaccines to immunize a patient against microbial infection.
    Type: Grant
    Filed: September 10, 2001
    Date of Patent: November 2, 2004
    Assignee: Microscience Limited
    Inventors: Martin John Glenton Hughes, Joseph David Santangelo, Jonathan Douglas Lane, Robert Feldman, Joanne Christine Moore, Richard James Dobson, Paul Everest, Gordon Dougan, Rebecca Kerry Wilson
  • Patent number: 6808917
    Abstract: Fungal/bacterial atagonist combinations, a seed coated with one of the combinations and a plant protected from plant pathogens by one of the combinations. The invention is also a fungal/bacterial antagonist combination and its use for controlling plant pathogens as a biocontrol agent, bio-pesticide or bio-fungicide.
    Type: Grant
    Filed: February 1, 2002
    Date of Patent: October 26, 2004
    Inventor: Thomas D. Johnson
  • Patent number: 6797507
    Abstract: The present invention describes a material and a method for controlling fungi. The method consists of disposing a naturally formed chitinase about an area to be protected. The naturally formed chitinase is produced from worm castings and the worm castings may be disposed naturally, in the form of timed-release pellets, or in a liquid form. The area to be protected includes plants and structures. The naturally formed chitinase may be disposed about the base of the plant or structure, or on the leaves of the plant.
    Type: Grant
    Filed: September 20, 2002
    Date of Patent: September 28, 2004
    Inventor: George E. Hahn
  • Patent number: 6787348
    Abstract: Liquid microbial starter culture that retains its initial metabolic activity during storage for extended periods of time. Such liquid starter cultures are useful in the manufacturing of food and feed products. Starter cultures of the invention include culture of lactic acid bacteria, e.g. Lactococcus species.
    Type: Grant
    Filed: December 22, 1999
    Date of Patent: September 7, 2004
    Assignee: CHR. Hansen
    Inventors: Boerge Kringelum, Lene Kragelund
  • Patent number: 6780317
    Abstract: A method of purifying waste water biologically by using three particularly suitable bacteria: Bacillus sp. DT-1, Pseudomonas azelaica, DT-2, and/or Rhizobus sp. DT-5, or mixed populations thereof. The invention further relates to the bacteria and the mixed populations and use thereof in purifying waste water. The invention further relates to a bioreactor including the bacteria.
    Type: Grant
    Filed: May 13, 2002
    Date of Patent: August 24, 2004
    Assignee: Oy Clewer Ltd
    Inventors: Jussi Uotila, Gennadi Zaitsev
  • Patent number: 6762280
    Abstract: In this application is described substrates for high-throughput assays of clostridial neurotoxin proteolytic activities. Two types of substrates are described for use in assays for the proteolytic activities of clostridial neurotoxins: (1) modified peptides or proteins that can serve as FRET substrates and (2) modified peptides or proteins that can serve as immobilized substrates. In both types a fluorescent molecules is present in the substrate, eliminating the requirement for the addition of a fluorigenic reagent. The assays described can be readily adapted for use in automated or robotic systems.
    Type: Grant
    Filed: September 25, 2001
    Date of Patent: July 13, 2004
    Assignee: The United States of America as represented by the Secretary of the Army
    Inventors: James J. Schmidt, Robert G. Stafford
  • Patent number: 6750049
    Abstract: A bioengineered synthesis scheme for the production of 1,2,3,4-tetrahydroxybenzene from a carbon source is provided. Methods of producing 1,2,3,4-tetrahydroxybenzene from a carbon source based on the synthesis scheme are also provided. Methods are also provided for converting 1,2,3,4-tetrahydroxybenzene to 1,2,3-trihydroxybenzene by catalytic hydrogenation.
    Type: Grant
    Filed: May 7, 2002
    Date of Patent: June 15, 2004
    Assignee: Board of Trustees operating Michigan State University
    Inventors: John W. Frost, Chad A. Hansen
  • Publication number: 20040110271
    Abstract: A process for treating waste comprising the steps of (i) adding a first innoculum comprising sulfide-utilizing bacteria to a sulfide-rich organic waste to produce a lowered-sulfide waste, (ii) adding a second innoculum comprising organic digesting bacteria to the lowered-sulfide waste to produce a digested waste, and (iii) adding to the digested waste at least one of (a) a third innoculum comprising bacteria capable of converting a nitrogen-containing compound to N2 to produce a lowered nitrogen waste, and (b) a fourth innoculum comprising phosphorous absorbing bacteria to produce a phosphorous enriched bacteria fraction and a phosphorous depleted waste fraction.
    Type: Application
    Filed: December 10, 2002
    Publication date: June 10, 2004
    Inventor: Gregory S. Patterson
  • Patent number: 6709853
    Abstract: Immobilized cell beads incorporating formulated microbial consortium comprising a synergistic mixture of the following bacterial strains namely, Enterobacter sakazaki, Pseudomonas aeruginosa and Aeromonas sobria selected from the following isolated bacterial strains namely, Yersinia enterocolitica, Aeromonas sobria, Klebsiella pneumoniae, Serratia liquefaciens, Enterobacter sakazaki, Citrobacter amalonaticus, Pseudomonas fluorescens, Pseudomonas aeruginosa, Enterobacter cloaca, Acinetobacter calcoaceticus are prepared, the formulated microbial consortium is immobilized in an appropriate immobilizing agent resulting in the formation of beads and the beads are used for instant BOD estimation using an electronic device and the formulated cell beads are reusable and are capable of assimilating most of the organic matter present in varied industrial effluents.
    Type: Grant
    Filed: April 3, 2001
    Date of Patent: March 23, 2004
    Assignee: Council of Scientific & Industrial Research
    Inventors: Rita Kumar, Shikha Rastogi, Alka Sharma, Tushya Kumar Saxena
  • Patent number: RE40023
    Abstract: A pharmaceutical composition containing several different bacteria including Streptococcus thermophilus, Lactobacilli and Bifidobacteria is disclosed. The bacteria are present in the composition at a total concentration of 1×1011 to 1×1013 per gram. Further, methods of using the pharmaceutical are disclosed which include treatment of a gastrointestinal disorder and hypercholestermia. Also a method for modulating a host's immune response is disclosed.
    Type: Grant
    Filed: March 15, 2006
    Date of Patent: January 22, 2008
    Inventor: Claudio DeSimone